av/alembic--big.svg

COM:ALEMBICPHARMACEUTICALS

Alembic Pharmaceuticals

  • Stock

Last Close

1,040.35

21/11 09:59

Market Cap

196.41B

Beta: -

Volume Today

54.80K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
revenue
18.20B
-
20.10B
10.43%
30.55B
51.99%
30.30B
0.82%
30.35B
0.16%
38.07B
25.42%
38.07B
0%
52.76B
38.61%
52.32B
0.84%
52.32B
0%
62.29B
19.05%
cost of revenue
7.59B
-
7.58B
0.12%
8.43B
11.12%
10.37B
23.11%
10.62B
2.40%
11.93B
12.36%
11.93B
0%
15.21B
27.48%
17.23B
13.27%
17.23B
0%
34.34B
99.28%
gross profit
10.61B
-
12.52B
17.98%
22.12B
76.75%
19.93B
9.93%
19.73B
1.00%
26.13B
32.46%
26.13B
0%
37.55B
43.69%
35.09B
6.56%
35.09B
0%
27.95B
20.35%
selling and marketing expenses
1.94B
-
2.45B
26.11%
2.74B
11.85%
3.93B
43.65%
3.80B
3.28%
5.90B
55.18%
5.90B
0%
6.96B
18.00%
8.90B
27.88%
8.90B
0%
general and administrative expenses
331.94M
-
423.50M
27.59%
517.36M
22.16%
1.45B
180.02%
1.10B
23.93%
1.35B
22.57%
1.35B
0%
2.09B
54.48%
2.11B
1.11%
2.11B
0%
selling general and administrative expenses
2.27B
-
2.87B
26.32%
3.25B
13.37%
5.38B
65.33%
4.90B
8.84%
7.25B
47.85%
7.25B
0%
9.05B
24.80%
11.01B
21.71%
11.01B
0%
21.34B
93.75%
research and development expenses
1.16B
-
1.22B
4.46%
3.07B
152.47%
982M
68.02%
368.60M
62.46%
302.70M
17.88%
302.70M
0%
253.80M
16.15%
505.90M
99.33%
505.90M
0%
4.39B
766.89%
other expenses
10.04M
-
17.32M
72.48%
6.74B
38,800.17%
2.50M
99.96%
300K
88%
2.30M
666.67%
2.30M
0%
2M
13.04%
1.30M
35%
17.64B
1,356,861.54%
283.10M
98.40%
cost and expenses
14.99B
-
16.57B
10.52%
21.19B
27.91%
24.91B
17.54%
25.25B
1.38%
30.49B
20.75%
30.49B
0%
39.79B
30.51%
46.39B
16.58%
46.39B
0%
55.68B
20.02%
operating expenses
7.40B
-
8.99B
21.43%
12.77B
42.08%
14.54B
13.86%
14.63B
0.65%
18.56B
26.84%
18.56B
0%
24.58B
32.45%
29.16B
18.63%
29.16B
0%
21.34B
26.82%
interest expense
104.00M
-
38.08M
63.39%
42.73M
12.22%
51.20M
19.82%
34M
33.59%
184.10M
441.47%
184.10M
0%
160.20M
12.98%
177.30M
10.67%
177.30M
0%
561.90M
216.92%
ebitda
3.59B
-
4.07B
13.22%
10.11B
148.39%
6.14B
39.26%
6.45B
5.02%
8.95B
38.86%
8.95B
0%
15.59B
74.22%
9.26B
40.65%
9.26B
0%
9.33B
0.84%
operating income
3.21B
-
3.53B
10.03%
9.36B
164.95%
5.39B
42.38%
5.10B
5.44%
7.41B
45.40%
7.57B
2.17%
12.97B
71.22%
5.87B
54.70%
6.39B
8.73%
6.61B
3.43%
depreciation and amortization
404.87M
-
444.13M
9.70%
722.14M
62.60%
829.70M
14.90%
1.05B
27.11%
1.15B
9.26%
1.15B
0%
1.83B
59.22%
2.87B
56.31%
2.87B
0%
167.90K
99.99%
total other income expenses net
-103.67M
-
58.86M
156.78%
-1.48M
102.52%
-138.40M
9,238.73%
314.20M
327.02%
-12.80M
104.07%
-81M
532.81%
1.03B
1,371.36%
379.30M
63.17%
-186.50M
149.17%
-278.80M
49.49%
income before tax
3.11B
-
3.59B
15.60%
9.36B
160.56%
5.25B
43.85%
5.41B
3.03%
7.49B
38.44%
7.49B
0%
13.68B
82.58%
6.20B
54.67%
6.20B
0%
6.33B
2.05%
income tax expense
751.03M
-
763.49M
1.66%
2.16B
182.93%
1.22B
43.43%
1.20B
1.51%
1.57B
30.25%
1.57B
0%
2.53B
61.61%
1.04B
58.76%
1.04B
0%
160M
84.68%
net income
2.36B
-
2.83B
20.13%
7.19B
154.29%
4.03B
43.96%
4.13B
2.35%
5.84B
41.62%
5.84B
0%
11.46B
96.19%
5.21B
54.56%
5.21B
0%
6.16B
18.21%
weighted average shs out
188.56M
-
188.49M
0.04%
188.52M
0.01%
188.52M
0%
188.52M
0%
188.52M
0%
188.52M
0%
193.74M
2.77%
196.56M
1.46%
196.56M
0%
196.56M
0.00%
weighted average shs out dil
188.56M
-
188.49M
0.04%
188.52M
0.01%
188.52M
0%
188.52M
0%
188.52M
0%
188.52M
0%
193.74M
2.77%
196.56M
1.46%
196.56M
0%
196.56M
0.00%
eps
12.49
-
15.01
20.18%
38.19
154.43%
21.39
43.99%
21.89
2.34%
31
41.62%
31
0%
59.18
90.90%
26.50
55.22%
26.50
0%
31.33
18.23%
epsdiluted
12.49
-
15.01
20.18%
38.19
154.43%
21.39
43.99%
21.89
2.34%
31
41.62%
31
0%
59.18
90.90%
26.50
55.22%
26.50
0%
31.33
18.23%

All numbers in (except ratios and percentages)